Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdams Regulatory News (ADA)

Share Price Information for Adams (ADA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 5.00
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 3.00 (60.00%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
ADA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

22 Jun 2016 07:00

RNS Number : 8842B
Adams PLC
22 June 2016
 

 

22 June 2016

Adams Plc

("Adams" or the "Company")

 

Annual Report and Financial Statements 2016

 

 

 

AUDITED RESULTS FOR THE YEAR ENDED 31 MARCH 2016

 

Adams Plc ("Adams" or the "Company) announces its audited financial results for the year ended 31 March 2016.

 

Highlights:

 

- Net assets at 31 March 2016 of €1.10 million (2015: €0.25 million).

- Loss after tax of €0.23 million (2015: €0.03 million.

- Investments at 31 March 2016 valued at €0.87 million represented by 4 AIM quoted holdings (2015: €0.17 million represented by 2 quoted holdings).

- Spend on new investments at a cost of €1.02 million (2015: €0.07 million). 

- Profitable realisations resulting in proceeds of €0.36 million (2015: €0.08 million).

- Share placing successfully completed resulting in 18,181,818 new ordinary shares being issued and funds of €1.08 million being raised.

 

Michael Bretherton, Chairman, said:

 

"The Board remains committed to delivering additional value for our shareholders and will continue to maintain a rigorous and highly selective investment approach with a view to exploiting opportunities as they emerge".

 

The Company's Annual Report 2016 will shortly be posted to shareholders and a copy will be made available on the Company's website at www.adamsplc.co.uk under the Investor Relations / Company & Shareholder Documents section. The Annual Report 2016 contains on page 25, a Notice of the Annual General Meeting to be held at 11.00 a.m. on Friday 2 September 2016 at IOMA House, Hope Street, Douglas, Isle of Man, IM1 1AP.

 

 

Enquiries:

 

Adams plc Michael Bretherton Tel: +44 1534 719 760

 

Nomad Cairn Financial Advisers LLP. Sandy Jamieson, James Caithie Tel: +44 207 148 7900

 

Broker Peterhouse Corporate Finance Limited. Heena Karani Tel: +44 207 469 3393 

 

Chairman's Statement

Adams Plc ("the Company") is an investing company focusing on the technology and life sciences sectors.

Adverse conditions in financial markets during the second half of the year had a negative impact on the carrying values of the quoted investment holdings of the Company which generated a positive gross investment return of only €30,000 in the year ended 31 March 2016 versus €172,000 in the year to 31 March 2015. As a result, and after allowing for administrative expenses of €219,000 and exchange translation losses of €45,000, Adams incurred a loss after tax for the year of €234,000 compared to a loss of €25,000 in the previous year.

I was appointed to the Board as a non-executive director in May of this year and subsequently took over the role of Chairman from Nicholas Nelson on his retirement at the Annual General Meeting of the Company on 11 September 2015. I thank Nicholas for all his work in completing the restructuring process of Adams in to an investing company. The Company also announced the appointment of Dr Andrew Mitchell as a non-executive director on 6 August 2015.

One of my first priorities on joining the Board was to seek to strengthen the Company's balance sheet by raising additional funds to be used to make investments in accordance with the Company's investing policy and for general working capital purposes. This was achieved by way of a placing of 18,181,818 new ordinary shares of €0.01 each with new and existing investors at a placing price of 4.4p (5.962 €cents) per ordinary share to raise £800,000 (€1,084,000) for the Company before expenses. The new shares were admitted to trading on AIM on 23 September 2015.

During the year to 31 March 2016, the Company invested €1,024,000 in five AIM listed technology businesses. One of these new investments was subsequently sold, and the Company also disposed of the two investments that it held at the 31 March 2015 financial year end, all for a total cash sale consideration of €357,000.

Adams currently holds four investments all of which are quoted on AIM, and for which the carrying value at 31 March 2016 was €871,000 (31 March 2015: €174,000 represented by the two quoted holdings that have since been sold).

At 31 March 2016, the Company had net assets of €1,100,000 inclusive of cash balances of €258,000 compared with net assets of €250,000 at 31 March 2015 inclusive of cash balances of €158,000. The increase in net assets is attributable to the receipt of €1,084,000 of share issue proceeds less the loss of €234,000 in the period.

Investments

The four AIM listed investments currently held by the Company comprise GVC Holdings PLC, Oxford Pharmascience Group Plc, Imagination Technologies Group Plc and Communisis Plc.

GVC is in a global online gaming and sports betting company with a solid on-line platform technology from which it operates some of the leading brands in the gaming sector including bwin, sporting bet, partypoker and Foxy Bingo. Oxford Pharmascience is a drug development company that re-develops approved drugs to make them better, safer and easier to take and it has a current focus to develop improved formulations of non-steroidal anti-inflammatory drugs (NSAIDs) and statins for global markets. Imagination is a global technology leader whose products include the key multimedia, communications and general purpose processors needed to power all mobile, consumer, automotive, automotive, enterprise and embedded electronics. Communisis is a leading processor technology company that creates unique, patented semiconductor IP for multimedia and communication applications.

Outlook

The potential for volatility in capital markets remains, given the continued worries over the slowdown in China's economy, together with persistent geopolitical risks in Ukraine and the Middle East and the need for further structural reforms to restore European public finances to a sustainable path. In addition, there is uncertainty over the UK referendum on its EU membership and also an expectation that a US interest rate rise is probable later this year.

 

The Board remains committed to delivering additional value for our shareholders and will continue to maintain a rigorous and highly selective investment approach with a view to exploiting opportunities as they emerge. We will also retain the management disciplines and shareholder alignment under which Adams now operates, whilst running a low cost base.

 

 

Michael Bretherton

Chairman

 

22 June 2016

 

 

 

Statement of Comprehensive Income for the year ended 31 March 2016

 

 

 

 

 

 

 

 

 

 

 

Year ended

31 Mar 2016

 

Year ended

31 Mar 2015

 

 

 

 

 

€'000

 

€'000

 

 

 

 

 

 

 

 

 

Gain on investments

 

 

 

 

 

30

 

 

172

 

Gross investment return

 

 

 

 

30

 

 

172

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net foreign exchange (loss)/gain

 

 

 

 

(45)

 

 

15

 

Administrative expenses

 

 

 

 

(219)

 

 

(212)

 

Operating loss

 

 

 

 

(234)

 

 

(25)

 

 

 

 

 

 

 

 

 

 

 

Loss on ordinary activities before taxation

 

 

 

 

(234)

 

 

(25)

 

 

 

 

 

 

 

 

 

 

 

Tax on gain/(loss) on ordinary activities

 

 

 

 

-

 

 

-

 

 

 

 

 

 

 

 

 

 

 

Loss for the year

 

 

 

 

(234)

 

 

(25)

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss for the year

 

 

 

 

(234)

 

 

(25)

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per share

 

 

 

 

(0.7)c

 

 

(0.1)c

 

 

 

Since there is no other comprehensive loss or gain, the loss for the year is the same as the total comprehensive loss for the year attributable to the owners of the Company.

 

Statement of Changes in Equity as at 31 March 2016

 

 

 

Share

Capital

Share

Premium

Accumulated

(Losses)

Total

 

 

€'000

€'000

€'000

€'000

 

 

 

 

 

 

At 1 April 2014

 

162

133

(170)

125

Changes in equity

 

 

 

 

 

Issue of shares

 

69

81

-

150

Total comprehensive (loss)

 

-

-

(25)

(25)

At 31 March 2015

 

231

214

(195)

250

 

 

 

 

 

 

Changes in equity

 

 

 

 

 

Issue of shares

 

182

902

-

1,084

Total comprehensive (loss)

 

-

-

(234)

(234)

At 31 March 2016

 

413

1,116

(429)

1,100

 

 

Statement of Financial Position at 31 March 2016

 

 

 

 

As at

31 March 2016

 

As at

31 March 2015

 

 

 

€'000

 

€'000

 

 

 

 

 

 

Assets

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

Investments

 

 

 

871

 

 

174

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Trade and other receivables

 

 

 

3

 

 

10

Cash and cash equivalents

 

 

 

258

 

 

158

Current assets

 

 

 

261

 

 

168

 

 

 

 

 

 

 

 

Total assets

 

 

 

1,132

 

 

342

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

Trade and other payables

 

 

 

(32)

 

 

(92)

Total liabilities

 

 

 

(32)

 

 

(92)

 

 

 

 

 

 

 

 

Net current assets

 

 

 

229

 

 

76

 

 

 

 

 

 

 

 

Net assets

 

 

 

1,100

 

 

250

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

Called up share capital

 

 

 

413

 

 

231

Share premium

 

 

 

1,116

 

 

214

Accumulated deficit

 

 

 

(429)

 

 

(195)

Total shareholder equity

 

 

 

1,100

 

 

250

 

 

 

 

 

 

 

 

 

 

Statement of Cash Flows for the year ended 31 March 2016

 

 

 

Year ended

 

Year ended

 

 

31 March 2016

 

31 March 2015

 

€'000

 

€'000

 

 

 

 

 

Loss for the year

 

 

(234)

 

 

(25)

Unrealised loss/(gain) on revaluation of investments

 

 

162

 

 

(128)

Realised (gain) on disposal of investments

 

 

(192)

 

 

(44)

Decrease/(increase) in trade and other receivables

 

 

7

 

 

(3)

(Decrease)/increase in trade and other payables

 

 

(60)

 

 

79

 

 

 

 

 

 

 

Net cash outflow from operating activities

 

 

(317)

 

 

(121)

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

Purchase of investments

 

 

(1,024)

 

 

(67)

Proceeds from sales of investments

 

 

357

 

 

79

 

 

 

 

 

 

 

Net cash (used)/generated in investing activities

 

 

(667)

 

 

12

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

Issue of ordinary share capital

 

 

182

 

 

69

Issue of premium share capital

 

 

902

 

 

81

 

 

 

 

 

 

 

Net cash generated from financing activities

 

 

1,084

 

 

150

 

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

 

100

 

 

41

Cash and cash equivalents at beginning of year

 

 

158

 

 

117

Cash and cash equivalents at end of year

 

 

258

 

 

158

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR AKDDQABKDCAB
Date   Source Headline
20th Dec 202310:15 amRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
26th Sep 20234:03 pmRNSHolding(s) in Company
18th Aug 20233:33 pmRNSResult of AGM
16th Aug 20231:04 pmRNSHolding(s) in Company
15th Aug 20233:37 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSFinal Results
9th Mar 20233:47 pmRNSAnnouncement by WANdisco
18th Jan 202312:00 pmRNSHolding(s) in Company
17th Jan 20234:18 pmRNSHolding(s) in Company
24th Nov 20227:00 amRNSHalf-year Report
26th Aug 20223:44 pmRNSResult of AGM
7th Jul 20227:00 amRNSFinal Results
26th Nov 20217:00 amRNSHalf-year Report
26th Aug 202111:29 amRNSResult of AGM
28th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSInvestment in Motif Bio Plc
7th May 202111:33 amRNSHolding(s) in Company
7th May 202111:30 amRNSHolding(s) in Company
7th May 20217:00 amRNSInvestment in Seeing Machines Limited
15th Apr 202112:48 pmRNSResult of Open Offer
26th Mar 20217:00 amRNSPlacing and Open Offer
26th Nov 20207:00 amRNSHalf-year Report
22nd Oct 202010:23 amRNSInvestment Commitment in C4X Discovery Holdings
21st Aug 202012:45 pmRNSResult of AGM
30th Jun 20207:00 amRNSFinal Results
19th Jun 20203:24 pmRNSAssignment of Shareholder Loan Facility
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSInvestment
19th Mar 20203:41 pmRNSStatement re COVID-19
11th Mar 20209:41 amRNSChange of Registered Office
3rd Jan 20207:00 amRNSInvestment
17th Dec 20198:57 amRNSDisposal
28th Nov 20197:00 amRNSHalf-year Report
9th Aug 201911:59 amRNSResult of AGM
3rd Jul 20197:00 amRNSFinal Results
29th Jan 20191:26 pmRNSShareholder Loan
27th Nov 20187:00 amRNSHalf-year Report
10th Aug 20182:01 pmRNSResult of AGM
26th Jun 20187:03 amRNSChange of Currency and AGM Proposals
26th Jun 20187:00 amRNSFinal Results
4th Jun 20189:56 amRNSHolding(s) in Company
4th Jun 20189:48 amRNSHolding(s) in Company
15th Dec 201712:55 pmRNSInvestment
28th Nov 20177:00 amRNSHalf-year Report
27th Nov 20172:07 pmRNSInvestment
6th Oct 201712:28 pmRNSDisposal
11th Sep 20175:06 pmRNSInvestment
8th Sep 20175:04 pmRNSResult of AGM and EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.